1 year return (CAGR)
71.03%
Minerva Neurosciences Inc Exchange (NASDAQ, USD)
NERV
3.66
+0.20 (+5.78%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-22.26%
5 year return (CAGR)
-22.81%
10 year return (CAGR)
-28.69%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
174.76M
Price/Sales
-
Ent value
446.75M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.80 |
| Daily high | 3.80 |
| Daily low | 3.43 |
| Daily Volume | 815K |
| All-time high | 117.60 |
| 1y analyst estimate | 10.33 |
| Beta | -0.10 |
| EPS (TTM) | -4.99 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 10 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NERV | S&P500 | |
| Current price drop from All-time high | -96.89% | -2.08% |
| Highest price drop | -98.86% | -56.47% |
| Date of highest drop | 9 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -66.04% | -10.68% |
| Avg time to new high | 205 days | 12 days |
| Max time to new high | 1588 days | 1805 days |
News
